Cargando…

Cisplatin‐resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib

De novo and acquired resistance to platinum therapy such as cisplatin (CDDP) is a clinical challenge in gastric cancer treatment. Aberrant expression and activation of aurora kinase A (AURKA) and eukaryotic translation initiation factor 4E (eIF4E) are detected in several cancer types. Herein, we inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lihong, Arras, Janet, Katsha, Ahmed, Hamdan, Saif, Belkhiri, Abbes, Ecsedy, Jeffrey, El‐Rifai, Wael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537695/ https://www.ncbi.nlm.nih.gov/pubmed/28417568 http://dx.doi.org/10.1002/1878-0261.12066

Ejemplares similares

Aurora kinase A in gastrointestinal cancers: time to target
por: Katsha, Ahmed, et al.
Publicado: (2015)

The Aurora kinase A Regulates GSK-3β in Gastric Cancer Cells
por: Dar, Altaf A, et al.
Publicado: (2008)

Scientific Rationale Supporting the Clinical Development Strategy for the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer
por: Niu, Huifeng, et al.
Publicado: (2015)

Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis
por: Zhu, Shoumin, et al.
Publicado: (2015)

Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer
por: Pitts, Todd M., et al.
Publicado: (2016)

ABCG2 impairs the activity of the aurora kinase inhibitor tozasertib but not of alisertib
por: Michaelis, Martin, et al.
Publicado: (2015)

MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
por: Sells, Todd B., et al.
Publicado: (2015)

Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor
por: Niu, Huifeng, et al.
Publicado: (2017)

TFF1 activates p53 through down-regulation of miR-504 in gastric cancer
por: Soutto, Mohammed, et al.
Publicado: (2014)

Advances in targeted therapies and new promising targets in esophageal cancer
por: Belkhiri, Abbes, et al.
Publicado: (2015)

Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies
por: Zhou, Xiaofei, et al.
Publicado: (2017)

Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia
por: Fathi, Amir T., et al.
Publicado: (2017)

DARPP-32: from neurotransmission to cancer
por: Belkhiri, Abbes, et al.
Publicado: (2016)

Effects of rifampin, itraconazole and esomeprazole on the pharmacokinetics of alisertib, an investigational aurora a kinase inhibitor in patients with advanced malignancies
por: Zhou, Xiaofei, et al.
Publicado: (2017)

t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer
por: Vangamudi, Bhavatarini, et al.
Publicado: (2010)

Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells
por: Ding, Yong-Hui, et al.
Publicado: (2015)

Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors
por: Falchook, Gerald S., et al.
Publicado: (2015)

Global population pharmacokinetics of the investigational Aurora A kinase inhibitor alisertib in cancer patients: rationale for lower dosage in Asia
por: Zhou, Xiaofei, et al.
Publicado: (2017)

Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells
por: Yuan, Chun-Xiu, et al.
Publicado: (2015)

Inhibition of Aurora Kinase A by Alisertib Reduces Cell Proliferation and Induces Apoptosis and Autophagy in HuH-6 Human Hepatoblastoma Cells
por: Tan, Jingyi, et al.
Publicado: (2020)

An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
por: Goldberg, Stuart L., et al.
Publicado: (2014)

Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells
por: Vangamudi, Bhavatarini, et al.
Publicado: (2011)

Alisertib promotes apoptosis and autophagy in melanoma through p38 MAPK-mediated aurora a signaling
por: Shang, Yuan-Yuan, et al.
Publicado: (2017)

Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma
por: Lu, Heng, et al.
Publicado: (2022)

Glutathione Peroxidase 7 Suppresses Bile Salt-Induced Expression of Pro-Inflammatory Cytokines in Barrett's Carcinogenesis
por: Peng, Dun-Fa, et al.
Publicado: (2014)

Loss of Tff1 Promotes Pro-Inflammatory Phenotype with Increase in the Levels of RORγt+ T Lymphocytes and Il-17 in Mouse Gastric Neoplasia
por: Soutto, Mohammed, et al.
Publicado: (2017)

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
por: Pidkovka, Nataliya, et al.
Publicado: (2023)

Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines
por: Liu, Ningbo, et al.
Publicado: (2019)

Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma
por: Saad, Rama, et al.
Publicado: (2013)

APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts
por: Hong, Jun, et al.
Publicado: (2016)

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
por: Kelly, Kevin R, et al.
Publicado: (2011)

Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis
por: Soutto, Mohammed, et al.
Publicado: (2015)

Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
por: Zhu, Shoumin, et al.
Publicado: (2019)

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
por: Punt, Simone, et al.
Publicado: (2020)

Combining selinexor with alisertib to target the p53 pathway in neuroblastoma
por: Nguyen, Rosa, et al.
Publicado: (2022)

Co-overexpression of AXL and c-ABL predicts a poor prognosis in esophageal adenocarcinoma and promotes cancer cell survival
por: Hong, Jun, et al.
Publicado: (2020)

An analog-sensitive allele of Aurora kinase B is lethal in mouse
por: Vazquez, Berta N., et al.
Publicado: (2021)

Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review
por: Gavriilidis, Paschalis, et al.
Publicado: (2015)

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation
por: Currier, Mark A., et al.
Publicado: (2017)

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models
por: Davis, S. Lindsey, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_98180u3rqade7u3fu2s45mmdnl